• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

NANOMOL TECHNOLOIES in the LABFORUM Workshops
27 July 2022

NANOMOL TECHNOLOIES in the LABFORUM Workshops

It's official!  

This October, NANOMOL TECHNOLOGIES #team will conduct a #workshop session under the title "#Design and #characterization of #particles and (nano)formulations as a tool for #innovation in drug #development and #manufacturing" in the LABFORUM Workshops at FARMAFORUM.  

On October 5th, you will be able to attend the training, from 15:30-17:30, accompanied by our #experts on #drugdelivery, #particleengineering, #nanoformulation and #particlecharacterization:  

➡️ Oscar Raposo Aymerich: Particle Analysis Unit Manager  
➡️ Lidia Ferrer-Tasies, PhD: R&D Director  
➡️ Alba Córdoba Insensé: Technology Transfer & Business Development Director  
➡️ Santi Sala Vergés: CEO 

In addition, we will talk about the PHOENIX OITB, the European #project that is setting -up a single-entry point for the #characterization, #testing, scale-up, and #GMP manufacturing of #nanopharmaceuticals. NANOMOL TECHNOLOGIES provides two #nanomedicine demo-cases based on proprietary DELOS nanoformulation #technology.  

Anyway, we will be happy to assist you at #stand B35, where we can talk in more detail about any issue or #collaboration you might have interest to discuss.  

Register at the following link to attend the Training or meet us at our stand B35.  

We look forward to seeing you there!

Related
news

New nanocarrier for bio-imaging and drug-delivery applications 24 January 2020

New nanocarrier for bio-imaging and drug-delivery applications

NANOMOL TECHNOLOGIES HAS STARTED THE TECNIOSPRING PLUS PROJECT (TECSPR18-1-0016) 16 May 2019

NANOMOL TECHNOLOGIES HAS STARTED THE TECNIOSPRING PLUS PROJECT (TECSPR18-1-0016)

Stable nanovesicles formed by intrinsically planar bilayers 15 December 2022

Stable nanovesicles formed by intrinsically planar bilayers

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2025

Nanomol Technologies S.L.

Site by Suki